Showing results (361-370 of 598) with videos related to
Sort By:
Pageof 60
Journal of the Neurological Sciences|September 9, 2019
Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE studyKhashayar Dashtipour, Zoltan Mari, Joseph Jankovic, et al.Immunobiology|October 4, 2011
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B moleculeM Zouhair Atassi, Joseph Jankovic, Lance E Steward, et al.Journal of the Neurological Sciences|December 19, 2006
Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian populationEng-King Tan, Jennie Lee, Christine Hunter, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 26, 2017
Are psychogenic non-epileptic seizures just another symptom of conversion disorder?Richard A A Kanaan, Roderick Duncan, Laura H Goldstein, et al.Stereotactic and Functional Neurosurgery|July 17, 2012
Deep brain stimulation hardware complications in patients with movement disorders: risk factors and clinical correlationsJosé Fidel Baizabal Carvallo, Giovanni Mostile, Mike Almaguer, et al.Brain Research|June 27, 2008
Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivoTianhong Pan, Wen Zhu, Hongru Zhao, et al.Neuroimage|April 21, 2009
Safety of MRI in patients with implanted deep brain stimulation devicesMichele Tagliati, Joseph Jankovic, Fernando Pagan, et al.The Journal of Comparative Neurology|December 2, 2005
Nurr1 in Parkinson's disease and related disordersYaping Chu, Weidong Le, Katie Kompoliti, et al.Experimental Neurology|July 24, 2010
Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patientsJongil Lim, Manjit K Sanghera, Olivier Darbin, et al.Molecular Immunology|May 2, 2006
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/ABehzod Z Dolimbek, K Roger Aoki, Lance E Steward, et al.Pageof 60